The short version: 7-OH products and plain kratom leaf are not the same category, and as of 2026 federal law is drawing a line between them. 7-OH is shorthand for 7-hydroxymitragynine, a minor alkaloid that occurs in the kratom plant in trace amounts — the DEA's own filing puts it at less than two percent of the leaf's total alkaloid content. The tablets, gummies, shots, and dissolvable films sold as "7-OH" in gas stations and smoke shops are something else: concentrated or semi-synthetic preparations that deliver far more of that single alkaloid than any leaf does.
That distinction is the whole story of 2026. On August 26, 2026 the DEA placed three 7-OH-related synthetic compounds into Schedule I, effective immediately. A separate action aimed at concentrated 7-OH above a specified threshold is still pending — the public comment period on it was extended and closes September 10, 2026. Neither action, as written, covers ordinary kratom leaf powder.
Safety & legal note. Kratom is not approved by the FDA for any use, and nothing here is medical advice or legal advice. This article reports the status of federal rulemaking as of September 2026; scheduling actions and state laws change, so confirm current status with an official source. Kratom is banned in some US states and is not for anyone under 21 — check your local law.
What 7-OH actually is
Kratom leaf contains dozens of alkaloids. Two get most of the attention: mitragynine, the major one, and 7-hydroxymitragynine, a minor one. In the plant, mitragynine dominates by a wide margin and 7-OH is present in trace quantities.
The complication is that 7-OH can be produced from mitragynine in a one-step chemical reaction, and it is also the compound your body converts mitragynine into after you consume it. A synthesised molecule and a naturally occurring one are chemically identical — DEA says so explicitly. What differs is the dose and the matrix. The agency's own framing is worth quoting, because it is unusually clear about why the two are treated differently:
"While consumers of raw plant matrix may experience a modified or attenuated physiological effect due to the competitive, co-occurring alkaloids inherent to M. speciosa, isolated or semi-synthetically derived formulations deliver unattenuated, high-potency effects of the target alkaloid directly."
In other words: leaf is a mixture in which alkaloids compete; a pressed 7-OH tablet is a single concentrated alkaloid with nothing else in the way. If you have read our piece on whether kratom is an opioid, this is the same pharmacology argument at a different concentration — and concentration is precisely what regulators reacted to.
What actually happened, and when
| Date | Action | Status |
|---|---|---|
| July 6, 2026 | DEA publishes notices of intent covering (a) 7-OH above a threshold and (b) three related synthetics | Notices only |
| Aug 26, 2026 | DEA temporary order places mitragynine pseudoindoxyl, MGM-15, MGM-16 in Schedule I | In effect to Aug 26, 2028 |
| Aug 26, 2026 | HHS extends comment period on the 7-OH threshold proposal | Comments close Sept 10, 2026 |
| Pending | Temporary scheduling order for concentrated 7-OH itself | Not yet published |
Two things follow from that table, and both get garbled in the coverage.
First: the compounds already scheduled are not what most 7-OH tablets contain. Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are synthetic derivatives. That order is final and effective.
Second: concentrated 7-OH itself is not federally scheduled as of this writing. The intent has been published, HHS transmitted its scientific evaluation in July 2025, and a temporary order was flagged for "on or after August 5, 2026" — but it has not appeared in the Federal Register yet, and the comment docket is still open. Anyone telling you 7-OH was banned outright in August is running ahead of the paperwork.
The threshold, in plain numbers
The proposed rule does not target the molecule at any concentration. It sets a line:
- Botanical material from Mitragyna speciosa containing more than 0.050% 7-OH on a dry weight basis, or
- Any processed article — extract, concentrate, edible, pressed pill — or synthetic product containing more than 0.050% by weight or volume, or more than 1.00 mg of 7-OH per article.
Below that line, the action does not apply. Ordinary leaf powder sits below it, which is why the American Kratom Association has spent the year arguing the two products should be regulated separately. Its senior fellow on public policy, Mac Haddow, has described the concentrated products as "chemically manipulated opioids that are not traditional kratom products" and holds that anything exceeding roughly 2% of total alkaloid content as 7-OH is not a kratom product at all.
Most state Kratom Consumer Protection Act laws already encode a version of that logic — capping 7-OH as a share of total alkaloids, requiring mitragynine and 7-OH content on the label, barring synthetic alkaloid spiking, and setting a 21+ purchase age. The caps vary by state, so the label is the thing to read.
Why this matters when you are buying
The practical consequence for a buyer is that "kratom" on a shelf now covers two very different things, and the packaging does not always make it obvious.
| Leaf powder / capsules | 7-OH tablets, shots, gummies | |
|---|---|---|
| What it is | Dried, milled leaf | Concentrated or semi-synthetic single alkaloid |
| 7-OH content | Trace — under the 0.050% line | Far above it, by design |
| Typical seller | Specialist vendors, lab-tested | Gas stations, smoke shops, vape counters |
| Federal status (Sept 2026) | Not scheduled | Threshold action pending; related synthetics scheduled |
| What the COA shows | Alkaloid %, heavy metals, microbials | Often nothing at all |
DEA's filing also records what users themselves report about the concentrated products: they describe transitioning from leaf to 7-OH tablets, describe the effect as more euphoric and lacking the nausea ceiling of plain leaf, and — the part that matters most — report a short-lived effect and an urge to redose frequently. That is a self-reported pattern from user forums, not a clinical finding, but it is the pattern that drove the scheduling action.
The defensive move is the same one we recommend everywhere on this site: buy leaf products from vendors who publish per-batch third-party testing, and read the alkaloid line on the COA. A certificate that states mitragynine and 7-OH percentages tells you which side of the line a product sits on. No certificate tells you nothing — see how to tell if kratom is clean for the rest of the checklist.
Where to buy
If you want plain leaf rather than concentrates, the three vendors we track all sell leaf powder and capsules with published lab testing, and all three hold AKA GMP qualification — the annually audited standard we describe in is kratom safe.
Our code getketum takes 15% off at Kraken Kratom — our #1 ranked vendor, AKA GMP qualified since the program launched in 2019, and the most specific of the three about its testing methods and published alkaloid averages. It is the one to start with if the paperwork is what you care about.
- Kats Botanicals — batch-number lookup that returns the COA for the exact lot in your hand, plus a broad powder and capsule menu.
- Kona Kratom — third-party tested value option with the cheapest bulk per-gram pricing we found, backed by a money-back guarantee.
The full ranked comparison, with testing weighted at 45%, is at best kratom vendors.
The bottom line
- 7-OH products and kratom leaf are different categories. 7-OH is a minor alkaloid — under 2% of the leaf's total alkaloid content — that concentrates and synthetics deliver at far higher levels.
- Three related synthetics are Schedule I as of August 26, 2026: mitragynine pseudoindoxyl, MGM-15, and MGM-16. That order runs to August 2028.
- Concentrated 7-OH itself is not federally scheduled yet. The threshold proposal is still open; comments close September 10, 2026.
- The proposed line is 0.050% by dry weight, or 1.00 mg per article. Ordinary leaf powder falls below it and is not covered as written.
- Federal status is not state status. Several states ban kratom outright and others cap 7-OH under their own laws — check where kratom is legal before you order.
- Read the alkaloid line on the COA. It is the only thing that tells you what is actually in the product, whatever the front of the package says.